Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMGN

ImmunoGen (IMGN) Stock Price, News & Analysis

ImmunoGen logo

About ImmunoGen Stock (NASDAQ:IMGN)

Advanced Chart

Key Stats

Today's Range
$31.23
$31.23
50-Day Range
$31.23
$31.23
52-Week Range
$3.61
$31.25
Volume
40 shs
Average Volume
8.78 million shs
Market Capitalization
$8.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoGen and its competitors with MarketBeat's FREE daily newsletter.

IMGN Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Artisan International Small-Mid Instl
Artisan International Small-Mid Advisor
See More Headlines

IMGN Stock Analysis - Frequently Asked Questions

ImmunoGen, Inc. (NASDAQ:IMGN) issued its quarterly earnings results on Monday, July, 31st. The biotechnology company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.14. ImmunoGen's revenue was up 485.9% on a year-over-year basis.
Read the conference call transcript
.

ImmunoGen subsidiaries include Hurricane LLC, ImmunoGen BioPharma (Ireland) Limited, ImmunoGen Europe Limited, and ImmunoGen Securities Corp..

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmunoGen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), GE Aerospace (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

Last Earnings
7/31/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IMGN
CIK
855654
Employees
277
Year Founded
1981

Profitability

EPS (Trailing Twelve Months)
($0.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
390.38
P/E Growth
N/A
Net Income
-$222.93 million
Net Margins
-25.56%
Pretax Margin
-25.24%
Return on Equity
-22.11%
Return on Assets
-13.53%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
5.70
Quick Ratio
5.65

Sales & Book Value

Annual Sales
$287.61 million
Price / Sales
28.91
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
43.99

Miscellaneous

Outstanding Shares
266,264,000
Free Float
252,764,000
Market Cap
$8.32 billion
Optionable
Optionable
Beta
1.18

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:IMGN) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners